Abstract
Alzheimer's disease (AD) is the most frequent neurodegenerative disorder worldwide and is especially aggressive in patients aged 65 years and over. Due to the current lack of satisfactorily effective drugs, particularly in advanced stages, early diagnosis has been consolidated as an essential tool to fight against the disease already in its prodromal phase. Thus, physiological indicators …